Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

Title:Heterocyclic Scaffolds: Centrality in Anticancer Drug Development

Volume: 16 Issue: 7

Author(s): Imran Ali, Mohammad Nadeem Lone, Zeid A. Al-Othman, Abdulrahman Al-Warthan and Mohd. Marsin Sanagi

Affiliation:

Keywords: Current challenges, future prospectives, heterocyclic compounds, market selling anticancer drugs, mechanisms of actions, recent advances, synthetic and natural heterocyclic compounds.

Abstract: Cancer has been cursed for human beings for long time. Millions people lost their lives due to cancer. Despite of the several anticancer drugs available, cancer cannot be cured; especially at the late stages without showing any side effect. Heterocyclic compounds exhibit exciting medicinal properties including anticancer. Some market selling heterocyclic anticancer drugs include 5-flourouracil, methortrexate, doxorubicin, daunorubicin, etc. Besides, some natural products such as vinblastine and vincristine are also used as anticancer drugs. Overall, heterocyclic moeities have always been core parts in the expansion of anticancer drugs. This article describes the importance of heterocyclic nuclei in the development of anticancer drugs. Besides, the attempts have been made to discuss both naturally occurring and synthetic heterocyclic compounds as anticancer agents. In addition, some market selling anticancer heterocyclic compounds have been described. Moreover, the efforts have been made to discuss the mechanisms of actions and recent advances in heterocyclic compounds as anticancer agents. The current challenges and future prospectives of heterocyclic compounds have also been discussed. Finally, the suggestions for syntheses of effective, selective, fast and human friendly anticancer agents are discussed into the different sections.

Cite this article as:

Ali Imran, Lone Nadeem Mohammad, Al-Othman A. Zeid, Al-Warthan Abdulrahman and Sanagi Marsin Mohd., Heterocyclic Scaffolds: Centrality in Anticancer Drug Development, Current Drug Targets 2015; 16 (7) . https://dx.doi.org/10.2174/1389450116666150309115922